Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2008

01-08-2008 | Original Paper

Helicobacter pylori Stool Antigen (HpSA) Tests in Children Before and After Eradication Therapy: Comparison of Rapid Immunochromatographic Assay and HpSA ELISA

Authors: Hye Ran Yang, Jeong Kee Seo

Published in: Digestive Diseases and Sciences | Issue 8/2008

Login to get access

Abstract

The rapid immunochromatography for Helicobacter pylori (H. pylori) stool antigen (rapid HpSA) test is a recently-developed method for detection of H. pylori infection. The objective of this study was to assess the pre and post-eradication diagnostic accuracy of the rapid HpSA test compared with the conventional HpSA immunoassay (HpSA ELISA) in children. Sensitivity, specificity, positive predictive value, and negative predictive value for the rapid HpSA test were 94.6, 98.4, 94.6, and 98.4%, respectively, and those for the HpSA ELISA were 94.6, 96.1, 87.5, and 98.4%, respectively. No significant difference was observed between the sensitivity and specificity of the two HpSA tests in children (P = 1.000 and P = 0.250) or the sensitivity and specificity of the two HpSA tests pre and post-eradication therapy (P = 1.000 and P = 1.000). The rapid HpSA and HpSA ELISA are reliable methods of detection of H. pylori infection in the pediatric population before and after eradication therapy.
Literature
1.
Crone J, Gold BD (2004) Helicobacter pylori infection in pediatrics. Helicobacter 9(suppl 1):49–56PubMedCrossRef
2.
Dzierzanowska-Fangrat K, Lehours P, Mégraud F, Dzierzanowska D (2006) Diagnosis of Helicobacter pylori infection. Helicobacter 11(suppl 1):6–13PubMedCrossRef
3.
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56:772–781PubMedCrossRef
4.
Czinn SJ (1999) Serodiagnosis of Helicobacter pylori in pediatric patients. J Pediatr Gastroenterol Nutr 28:132–134PubMedCrossRef
5.
Yang HR, Seo JK (2005) Diagnostic accuracy of the 13C-urea breath test in children: adjustment of the cut-off value according to age. J Gastroenterol Hepatol 20:264–269PubMedCrossRef
6.
Kindermann A, Demmelmair H, Koletzko B, Krauss-Etschmann S, Wiebecke B, Koletzko S (2000) Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 30:85–91PubMedCrossRef
7.
Gisbert JP, Pajares JM (2004) Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter 9:347–368PubMedCrossRef
8.
Kaklikkaya N, Akdogan RA, Ozgur O, Uzun DY, Cobanoglu U, Dinc U, Gungor E, Dabanca PA, Arslan M, Aydin F, Erturk M (2006) Evaluation of a new rapid lateral flow chromatography test for the diagnosis of Helicobacter pylori. Saudi Med J 27:799–803PubMed
9.
Wu IC, Ke HL, Lo YC, Yang YC, Chuang CH, Yu FJ, Lee YC, Jan CM, Wang WM, Wu DC (2003) Evaluation of a newly developed office-based stool test for detecting Helicobacter pylori: an extensive pilot study. Hepatogastroenterology 50:1761–1765PubMed
10.
Kato S, Ozawa K, Okuda M, Nakayama Y, Yoshimura N, Konno M, Minoura T, Iinuma K (2004) Japan pediatric Helicobacter study group. Multicenter comparison of rapid lateral flow stool antigen immunoassay and stool antigen enzyme immunoassay for the diagnosis of Helicobacter pylori infection in children. Helicobacter 9:669–673PubMedCrossRef
11.
Kolho KL, Klemola T, Koivusalo A, Rautelin H (2006) Stool antigen tests for the detection of Helicobacter pylori in children. Diagn Microbiol Infect Dis 55:269–273PubMedCrossRef
12.
Schwarzer A, Lottspeich C, Rüssmann H, Ossiander G, Koletzko S (2007) Evaluation of a novel rapid one-step monoclonal chromatographic immunoassay for detection of Helicobacter pylori in stool from children. Eur J Clin Microbiol Infect Dis 26:475–480PubMedCrossRef
13.
Vaira D, Malfertheiner P, Mègraud F, Axon A, Deltenre M, Hirschl AM, Gasbarrini G, O’Morain C, Garcia JM, Quina M, Tytgat GN (1999) Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet 354:30–33PubMedCrossRef
14.
Oderda G, Rapa A, Ronchi B, Lerro P, Pastore M, Staiano A, de’Angelis GL, Strisciuglio P (2000) Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ 320:347–348PubMedCrossRef
15.
Konstantopoulos N, Rüssmann H, Tasch C, Sauerwald T, Demmelmair H, Autenrieth I, Koletzko S (2001) Evaluation of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children. Am J Gastroenterol 96:677–683PubMedCrossRef
16.
Gosciniak G, Przondo-Mordarska A, Iwanczak B, Blitek A (2003) Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment. J Pediatr Gastroenterol Nutr 36:376–380PubMedCrossRef
17.
Trevisani L, Sartori S, Rossi MR, Ruina M, Matarese V, Gullini S, Abbasciano V (2005) Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study. Aliment Pharmacol Ther 21:485–489PubMedCrossRef
18.
Kalach N, Nguyen VB, Bergeret M, Boutros N, Dupont C, Raymond J (2005) Usefulness and influence of age of a novel rapid monoclonal enzyme immunoassay stool antigen for the diagnosis of Helicobacter pylori infection in children. Diagn Microbiol Infect Dis 52:157–160PubMedCrossRef
19.
Antos D, Crone J, Konstantopoulos N, Koletzko S (2005) Evaluation of a novel rapid one-step immunochromatographic assay for detection of monoclonal Helicobacter pylori antigen in stool samples from children. J Clin Microbiol 43:2598–2601PubMedCrossRef
20.
Makristathis A, Barousch W, Pasching E, Binder C, Kuderna C, Apfalter P, Rotter ML, Hirschl AM (2000) Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. J Clin Microbiol 38:3710–3714PubMed
21.
Oderda G, Rapa A, Marinello D, Ronchi B, Zavallone A (2001) Usefulness of Helicobacter pylori stool antigen test to monitor response to eradication treatment in children. Aliment Pharmacol Ther 15:203–206PubMedCrossRef
22.
Roggero P, Bonfiglio A, Luzzani S, Valade A, Cataliotti E, Corno G, Garaschi MC, Carissimi E, Mosca F, Carnelli V (2002) Helicobacter pylori stool antigen test: a method to confirm eradication in children. J Pediatr 140:775–777PubMedCrossRef
Metadata
Title
Helicobacter pylori Stool Antigen (HpSA) Tests in Children Before and After Eradication Therapy: Comparison of Rapid Immunochromatographic Assay and HpSA ELISA
Authors
Hye Ran Yang
Jeong Kee Seo
Publication date
01-08-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-0131-8

Other articles of this Issue 8/2008

Digestive Diseases and Sciences 8/2008 Go to the issue

Original Paper

Dietary Lipids Alter the Effect of Steroids on the Transport of Fructose Following Intestinal Resection in Rats

Original Paper

Celiac Disease and Non-organ-specific Autoantibodies in Patients with Chronic Hepatitis C Virus Infection

Original Paper

RETRACTED ARTICLE: Gastric Changes Following Colchicine Therapy in Patients with FMF

Original Paper

Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) Activity in the Sera of Patients with Pancreatic Cancer

Original Paper

Oxidative Stress, Inflammation and Neutrophil Superoxide Release in Patients with Crohn’s Disease: Distinction Between Active and Non-active Disease

Original Paper

Protective Effects of Diets Supplemented with Omega-3 Polyunsaturated Fatty Acids and Calcium Against Colorectal Tumor Formation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits